|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.55 USD | -6.05% |
|
-15.62% | -18.45% |
| 15/05 | Sarepta's Elevidys Faces 'Little' Pressure After Regenxbio Data, Wedbush Says | MT |
| 14/05 | Regenxbio shares sink as safety concerns overshadow muscle disorder therapy trial win | RE |
Chart calendar Sarepta Therapeutics, Inc.
Upcoming events on Sarepta Therapeutics, Inc.
| 04/06/2026 | Présentation aux Actionnaires / Analystes | 07:30 pm |
| 04/06/2026 | Annual General Meeting | Day |
Past events on Sarepta Therapeutics, Inc.
| 07/05/2026 | Earnings release - Q1 2026 | |
| 07/05/2026 | Earnings presentation | 02:00 am |
| 25/03/2026 | Information meeting | 06:00 pm |
| 26/02/2026 | Earnings presentation | 03:00 am |
| 26/02/2026 | Earnings release - Q4 2025 | |
| 26/01/2026 | Information meeting | 07:00 pm |
| 04/11/2025 | Earnings presentation | 03:00 am |
| 04/11/2025 | Earnings release - Q3 2025 | |
| 07/08/2025 | Earnings release - Q2 2025 | |
| 18/07/2025 | Présentation aux Actionnaires / Analystes | 08:00 pm |
| 17/07/2025 | Information meeting | 02:00 am |
| 16/06/2025 | Information meeting | 05:30 pm |
| 05/06/2025 | Annual General Meeting | 07:30 pm |
| 05/06/2025 | Présentation aux Actionnaires / Analystes | 07:30 pm |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 243 1 233 0.87% | 1 902 1 842 3.26% | 2 198 2 137 2.88% | 1 830 | 1 415 | 1 399 |
|
EBITDA Million USD | Released Forecast Spread | -223 -278 19.63% | 256 263 -2.59% | -658 -363 -81.31% | 516 | 51,5 | 170 |
|
EBIT Million USD | Released Forecast Spread | -268 -303 11.68% | 218 180 21.06% | -700 -414 -69.12% | 451 | 95,1 | 30,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -520 -559 6.94% | 261 271 -3.64% | -702 -563 -24.7% | 471 | 119 | 84,6 |
|
Net income Million USD | Released Forecast Spread | -536 -579 7.41% | 235 256 -8.08% | -713 -543 -31.36% | 399 | 83,7 | 76,7 |
|
EPS USD | Released Forecast Spread | -5,80 -6,39 9.19% | 2,34 2,68 -12.84% | -7,13 -5,36 -33.05% | 3,47 | 0,82 | 0,70 |
| Announcement Date | 28/02/24 | 26/02/25 | 25/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 467 405 15.33% | 658 631 4.34% | 745 684 8.88% | 611 531 15.07% | 399 337 18.49% | 443 391 13.3% | 731 475 53.85% | 361 | 367 | 376 | 366 | 371 | 375 | 379 |
|
EBITDA Million USD | Released Forecast Spread | 172 222 -22.53% | -290 -371 21.73% | 126 107 17.88% | -91,2 -93,4 2.4% | -401 -144 -178.13% | 368 245 50.09% | 44,5 | 60,5 | 64,1 | 32,9 | ||||
|
EBIT Million USD | Released Forecast Spread | 22,2 -28,2 178.8% | 162 182 -11.18% | -300 -247 -21.79% | 116 90,4 27.81% | -103 -98,3 -5.18% | -412 -136 -201.72% | 358 127 183.14% | 34,4 | 35,5 | 49,4 | 19,1 | 24,5 | 33,1 | 37,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 34,0 -18,4 284.62% | 172 191 -10.2% | -384 -219 -75.28% | 154 87,9 74.71% | -194 -94,6 -105.1% | -408 -131 -211.57% | 343 119 188.54% | 44,6 | 44,3 | 56,8 | 10,6 | 31,7 | 32,8 | 45,5 |
|
Net income Million USD | Released Forecast Spread | 33,6 -21,7 254.95% | 159 190 -16.41% | -448 -253 -76.9% | 197 82,3 139.15% | -180 -93,0 -93.43% | -412 -126 -228.16% | 331 75,1 340.64% | 28,6 | 26,4 | 46,1 | -4,91 | 20,9 | 23,4 | 33,2 |
|
EPS USD | Released Forecast Spread | 0,34 -0,16 311.23% | 1,50 1,88 -20.33% | -4,60 -1,53 -200.73% | 1,89 0,67 180.35% | -1,80 -0,93 -93.47% | -3,93 -1,25 -215.55% | 2,88 1,09 164.19% | 0,22 | 0,20 | 0,33 | 0,14 | 0,26 | 0,24 | 0,25 |
| Announcement Date | 06/11/24 | 26/02/25 | 06/05/25 | 06/08/25 | 03/11/25 | 25/02/26 | 06/05/26 | - | - | - | - | - | - | - |
Past sector events for Sarepta Therapeutics, Inc.
| 14/05/2026 |  | Annual General Meeting | 09:00 pm |
| 14/05/2026 | | Présentation aux Actionnaires / Analystes | 09:00 pm |
| 06/05/2026 | | Earnings presentation | 02:30 am |
| 13/02/2026 | | Earnings presentation | 03:30 am |
| 05/11/2025 | | Earnings presentation | 03:30 am |
| 06/08/2025 | | Earnings presentation | 02:30 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SRPT Stock
- Calendar Sarepta Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition